EIB grants Elekta over SEK 1.1 billion loan for new cancer treatments
Medical technology company Elekta is receiving a loan of just over SEK 1.1 billion from the European Investment Bank (EIB) to develop new cancer treatments.
BusinessMedical technology company Elekta is receiving a loan of just over SEK 1.1 billion from the European Investment Bank (EIB) to develop new cancer treatments.
Business